|
Lateral Flow Immunoassays For Pharmacokinetic Dosing Of Monoclonal Antibodies
|
1R41CA192697-01
|
$222,135
|
$222,135
|
MESSMER, BRADLEY
|
ABREOS BIOSCIENCES, INC.
|
|
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
|
1R01CA182284-01A1
|
$346,525
|
$346,525
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
|
1R01CA178394-01A1
|
$346,525
|
$346,525
|
GAVATHIOTIS, EVRIPIDIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$6,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$11,880
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$286,820
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The p110 alpha and delta isoforms of PI3 kinase in hematopoiesis and leukemia
|
7K08CA149208-05
|
$177,659
|
$177,659
|
GRITSMAN, KIRA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Targeting PML for therapy in leukemia-initiating cells
|
5R00CA139009-05
|
$241,530
|
$241,530
|
ITO, KEISUKE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The role of c-Maf in Stem cells in Leukemia
|
5F31CA162770-04
|
$42,676
|
$21,338
|
OKOYE, UJUNWA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia
|
5R01CA166429-02
|
$372,812
|
$372,812
|
STEIDL, ULRICH
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
$33,100
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Charge sensitive optical detection for high throughput study of small molecules
|
5R21CA173205-03
|
$193,043
|
$193,043
|
TAO, NONGJIAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
$16,206
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
DISCOVERY OF SMALL MOLECULAR ACTIVATORS OF NR4A ORPHAN NUCLEAR RECEPTORS
|
5R01CA160747-03
|
$314,996
|
$314,996
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
|
1R01CA183252-01A1
|
$531,196
|
$531,196
|
GOODELL, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
Germline Telomere Biology Defects in Pediatric and Young Adult Acute Myeloid Leuk
|
5K23CA158148-03
|
$168,757
|
$168,757
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
5P50CA126752-08
|
$2,162,000
|
$799,940
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
3R01CA164024-02S1
|
$3,941
|
$3,941
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
5R01CA164024-02
|
$322,104
|
$322,104
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Development of a Novel Mouse Model to Evaluate HTLV Tax Transformation
|
5R21CA175404-02
|
$165,096
|
$165,096
|
MARRIOTT, SUSAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
$6,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
$3,907
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
$11,984
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
$219,739
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
1R01CA175026-01A1
|
$405,847
|
$405,847
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-29S1
|
$86,403
|
$1,728
|
NICHOLS, CRAIG
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Determining the role of DNMT-interacting RNAs in myeloid disorders
|
1K99CA188595-01
|
$109,361
|
$109,361
|
DI RUSCIO, ANNALISA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-05
|
$339,713
|
$84,928
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting PML for leukemia therapy.
|
5R01CA142874-05
|
$436,776
|
$436,776
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
|
1K99CA183914-01A1
|
$169,668
|
$169,668
|
WAN, LIXIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Lig4R278H contribution to HSC and IgH class switching defects and malignancies
|
5R01CA161151-02
|
$357,586
|
$178,793
|
YAN, CATHERINE
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
CLL Mutation Detection and Monitoring from Blood using AC Electrokinetics
|
1R43CA183414-01
|
$224,603
|
$224,603
|
KRISHNAN, RAJARAM
|
BIOLOGICAL DYNAMICS, INC.
|
|
Rapid Testing of Drug Resistant BCR-ABL(+) Leukemia Cells
|
5R44CA153614-03
|
$600,237
|
$600,237
|
RIEDER, RONALD
|
BIOSENSE TECHNOLOGIES, INC.
|
|
""Oncorequisite"" Genes in MYC-mediated Transformation
|
5R00CA134743-05
|
$234,037
|
$187,230
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Mechanism of Notch-induced leukemogenesis in lymphocytes
|
1R21CA176811-01A1
|
$226,341
|
$226,341
|
WINANDY, SUSAN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Oncogenic Notch Signaling
|
3P01CA119070-08S1
|
$56,850
|
$34,679
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Oncogenic Notch Signaling
|
5P01CA119070-08
|
$982,910
|
$599,575
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
1U10CA180821-01
|
$10,540,919
|
$1,581,138
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S1
|
$228,063
|
$34,209
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S2
|
$264,661
|
$39,699
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S3
|
$16,838
|
$2,526
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B Human Specimen Repositories
|
3U24CA114725-09S1
|
$1,014,550
|
$507,275
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
2P01CA066996-16A1
|
$2,307,647
|
$2,307,647
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Tribbles-COP1 Complex in Leukemia
|
5K08CA166227-02
|
$178,200
|
$178,200
|
ULJON, SACHA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mapping the transcriptional regulatory circuits of human hematopoiesis
|
5F32CA168253-03
|
$53,282
|
$53,282
|
CHENG, CHRISTINE
|
BROAD INSTITUTE, INC.
|
|
Broad Institute Center for Cancer Systems Biology
|
5U54CA112962-10
|
$2,106,778
|
$526,695
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
MicroRNA-125b physiologically and pathologically regulates myelopoiesis through I
|
1F30CA183220-01
|
$42,676
|
$42,676
|
MEHTA, ARNAV
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Bcl-2 function on the endoplasmic reticulum
|
5R01CA085804-15
|
$275,915
|
$110,366
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-24S1
|
$74,051
|
$1,481
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-24S2
|
$29,166
|
$583
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
Total relevant funding to Leukemia for this search: $236,731,918
|